Paradis V - Search Results

1

Nestin as a diagnostic and prognostic marker for combined hepatocellular-cholangiocarcinoma.

Calderaro J, Di Tommaso L, Maillé P, Beaufrère A, Nguyen CT, Heij L, Gnemmi V, Graham RP, Charlotte F, Chartier S, Wendum D, Vij M, Allende D, Diaz A, Fuster C, Rivière B, Herrero A, Augustin J, Evert K, Calvisi DF, Leow WQ, Leung HHW, Bednarsch J, Boleslawski E, Rela M, Chan AW, Forner A, Reig M, Pujals A, Favre L, Allaire M, Scatton O, Uguen A, Trépo E, Sanchez LO, Chatelain D, Remmelink M, Boulagnon-Rombi C, Bazille C, Sturm N, Menahem B, Frouin E, Tougeron D, Tournigand C, Kempf E, Kim H, Ningarhari M, Michalak-Provost S, Kather JN, Gouw ASH, Gopal P, Brustia R, Vibert E, Schulze K, Rüther DF, Weidemann SA, Rhaiem R, Nault JC, Laurent A, Amaddeo G, Regnault H, de Martin E, Sempoux C, Navale P, Shinde J, Bacchuwar K, Westerhoff M, Lo RC, Sebbagh M, Guettier C, Lequoy M, Komuta M, Ziol M, Paradis V, Shen J, Caruso S. Calderaro J, et al. Among authors: paradis v. J Hepatol. 2022 Dec;77(6):1586-1597. doi: 10.1016/j.jhep.2022.07.019. Epub 2022 Aug 18. J Hepatol. 2022. PMID: 35987274

2

Progression of liver fibrosis in women infected with hepatitis C: long-term benefit of estrogen exposure.

Di Martino V, Lebray P, Myers RP, Pannier E, Paradis V, Charlotte F, Moussalli J, Thabut D, Buffet C, Poynard T. Di Martino V, et al. Among authors: paradis v. Hepatology. 2004 Dec;40(6):1426-33. doi: 10.1002/hep.20463. Hepatology. 2004. PMID: 15565616

3

Comparative protein expression profiles of hilar and peripheral hepatic cholangiocarcinomas.

Guedj N, Zhan Q, Perigny M, Rautou PE, Degos F, Belghiti J, Farges O, Bedossa P, Paradis V. Guedj N, et al. Among authors: paradis v. J Hepatol. 2009 Jul;51(1):93-101. doi: 10.1016/j.jhep.2009.03.017. Epub 2009 Apr 25. J Hepatol. 2009. PMID: 19446907

4

Prevalence of sclerosing cholangitis in adults with autoimmune hepatitis: a prospective magnetic resonance imaging and histological study.

Lewin M, Vilgrain V, Ozenne V, Lemoine M, Wendum D, Paradis V, Ziol M, Arrivé L, Beaugrand M, Poupon R, Valla D, Chazouillères O, Corpechot C. Lewin M, et al. Among authors: paradis v. Hepatology. 2009 Aug;50(2):528-37. doi: 10.1002/hep.23024. Hepatology. 2009. PMID: 19575454

5

Tolerance and outcome of patients with unresectable hepatocellular carcinoma treated with sorafenib.

Ozenne V, Paradis V, Pernot S, Castelnau C, Vullierme MP, Bouattour M, Valla D, Farges O, Degos F. Ozenne V, et al. Among authors: paradis v. Eur J Gastroenterol Hepatol. 2010 Sep;22(9):1106-10. doi: 10.1097/MEG.0b013e3283386053. Eur J Gastroenterol Hepatol. 2010. PMID: 20300004

6

Epithelial-to-mesenchymal transition and acquired resistance to sunitinib in a patient with hepatocellular carcinoma.

Marijon H, Dokmak S, Paradis V, Zappa M, Bieche I, Bouattour M, Raymond E, Faivre S. Marijon H, et al. Among authors: paradis v. J Hepatol. 2011 May;54(5):1073-8. doi: 10.1016/j.jhep.2010.11.011. Epub 2010 Dec 2. J Hepatol. 2011. PMID: 21145871 Free article.

7

Hepatocellular adenomas: accuracy of magnetic resonance imaging and liver biopsy in subtype classification.

Ronot M, Bahrami S, Calderaro J, Valla DC, Bedossa P, Belghiti J, Vilgrain V, Paradis V. Ronot M, et al. Among authors: paradis v. Hepatology. 2011 Apr;53(4):1182-91. doi: 10.1002/hep.24147. Hepatology. 2011. PMID: 21480324

8

Comparison of eight diagnostic algorithms for liver fibrosis in hepatitis C: new algorithms are more precise and entirely noninvasive.

Boursier J, de Ledinghen V, Zarski JP, Fouchard-Hubert I, Gallois Y, Oberti F, Calès P; multicentric groups from SNIFF 32, VINDIAG 7, and ANRS/HC/EP23 FIBROSTAR studies. Boursier J, et al. Hepatology. 2012 Jan;55(1):58-67. doi: 10.1002/hep.24654. Hepatology. 2012. PMID: 21898504

9

Benefit of initial resection of hepatocellular carcinoma followed by transplantation in case of recurrence: an intention-to-treat analysis.

Fuks D, Dokmak S, Paradis V, Diouf M, Durand F, Belghiti J. Fuks D, et al. Among authors: paradis v. Hepatology. 2012 Jan;55(1):132-40. doi: 10.1002/hep.24680. Hepatology. 2012. PMID: 21932387

10

Immunohistochemical markers on needle biopsies are helpful for the diagnosis of focal nodular hyperplasia and hepatocellular adenoma subtypes.

Bioulac-Sage P, Cubel G, Taouji S, Scoazec JY, Leteurtre E, Paradis V, Sturm N, Nhieu JT, Wendum D, Bancel B, Ramos J, Paraf F, Saint Paul MC, Michalak S, Fabre M, Guettier C, Le Bail B, Zucman-Rossi J, Balabaud C. Bioulac-Sage P, et al. Among authors: paradis v. Am J Surg Pathol. 2012 Nov;36(11):1691-9. doi: 10.1097/PAS.0b013e3182653ece. Am J Surg Pathol. 2012. PMID: 23060349

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

508 results

Search Page

Filters